Potential for an approval trial to start straight after the phase 1 trial is complete. So a cap raise for a market making event would, in my eyes at least, be a very positive thing.
Pipeline in cutting edge stuff. CarT for solid tumor. Natural Killer tech. Both of which have potential in several indications.
A $aud85 million market cap is very cheap.
CHM Price at posting:
25.5¢ Sentiment: Buy Disclosure: Held
